与癌共舞 - 临床入组

与癌共舞 - 临床入组 https://aww.yuaigongwu.com/forum-283-1.html Latest 20 threads of 临床入组 Copyright(C) 与癌共舞 Discuz! Board by Comsenz Inc. Thu, 09 Apr 2026 22:11:01 +0000 60 https://aww.yuaigongwu.com/static/image/common/logo_88_31.gif 与癌共舞 https://aww.yuaigongwu.com/ 临床试验招募| TROP2 ADC 临床项目汇总 https://aww.yuaigongwu.com/thread-131064-1-1.html 临床入组新药情报站-站长 Thu, 09 Apr 2026 03:00:12 +0000 新药情报早知道|阿替利珠单抗联合化疗降低肠癌患者复发和死亡风险50%，生存获益提升 https://aww.yuaigongwu.com/thread-131048-1-1.html 临床入组新药情报站-站长 Wed, 08 Apr 2026 02:44:58 +0000 新药情报早知道| HS-10241+阿美替尼在EGFR-TKI耐药患者中实现高达84%的疾病控制率 https://aww.yuaigongwu.com/thread-131038-1-1.html 临床入组新药情报站-站长 Tue, 07 Apr 2026 08:45:58 +0000 新药情报早知道| 破解EGFR耐药密码：针对“MET”的精准反击战已打响 https://aww.yuaigongwu.com/thread-131019-1-1.html 临床入组新药情报站-站长 Mon, 06 Apr 2026 12:43:01 +0000 4月汇总：临床试验招募| 肝胆胰等消化道肿瘤 https://aww.yuaigongwu.com/thread-131000-1-1.html 临床入组新药情报站-站长 Fri, 03 Apr 2026 08:46:12 +0000 新药情报早知道| 中国核药历史性突破，全球首个SPECT肿瘤显像剂“吉伦泰”获批上市 https://aww.yuaigongwu.com/thread-130997-1-1.html 临床入组新药情报站-站长 Fri, 03 Apr 2026 05:22:29 +0000 抗癌策略：如何将临床试验纳入你的治疗规划 https://aww.yuaigongwu.com/thread-130993-1-1.html 临床入组新药情报站-站长 Fri, 03 Apr 2026 01:37:50 +0000 新药情报早知道| 靶向KRAS G12D的新药Setidegrasib I期数据登上NEJM https://aww.yuaigongwu.com/thread-130986-1-1.html 临床入组新药情报站-站长 Thu, 02 Apr 2026 08:40:37 +0000 4月汇总：临床试验招募| MET 突变/扩增/过表达的非小细胞肺癌 https://aww.yuaigongwu.com/thread-130985-1-1.html 临床入组新药情报站-站长 Thu, 02 Apr 2026 08:26:53 +0000 新药情报早知道| 荣昌生物双抗ADC药物RC288获CDE临床试验许可，治疗恶性实体肿瘤 https://aww.yuaigongwu.com/thread-130981-1-1.html 临床入组新药情报站-站长 Thu, 02 Apr 2026 07:30:16 +0000 乱吃药！小心丢了新药入组机会 https://aww.yuaigongwu.com/thread-130977-1-1.html 临床入组新药情报站-站长 Thu, 02 Apr 2026 02:18:37 +0000 汇总：临床试验招募 | ADC新药机会，治疗经治NSCLC https://aww.yuaigongwu.com/thread-130968-1-1.html 临床入组新药情报站-站长 Wed, 01 Apr 2026 07:48:11 +0000 新药情报早知道| 百济神州ADAM9 ADC新药BG-C0979获批临床，治疗晚期实体瘤 https://aww.yuaigongwu.com/thread-130967-1-1.html 临床入组新药情报站-站长 Wed, 01 Apr 2026 07:01:44 +0000 3月汇总：临床试验招募| EGFR 20插入及其他少见突变肺癌患者 https://aww.yuaigongwu.com/thread-130966-1-1.html 临床入组新药情报站-站长 Wed, 01 Apr 2026 03:44:46 +0000 新药情报早知道|芦康沙妥珠单抗联合K药拟纳入优先审评 https://aww.yuaigongwu.com/thread-130965-1-1.html 临床入组新药情报站-站长 Wed, 01 Apr 2026 03:15:31 +0000 新药情报早知道| 科赛优®（司美替尼）现在大人也能用了！ https://aww.yuaigongwu.com/thread-130959-1-1.html 临床入组新药情报站-站长 Tue, 31 Mar 2026 09:59:55 +0000 新药情报早知道| 复宏汉霖H药汉斯状®获EMA积极意见, 新增两项新适应症 https://aww.yuaigongwu.com/thread-130958-1-1.html 临床入组新药情报站-站长 Tue, 31 Mar 2026 09:41:26 +0000 临床试验招募| MET过表达的非鳞非小细胞肺癌经治患者：Telisotuzumab Vedotin https://aww.yuaigongwu.com/thread-130957-1-1.html 临床入组新药情报站-站长 Tue, 31 Mar 2026 09:20:25 +0000 那个拒当“小白鼠”的病友，后悔了 https://aww.yuaigongwu.com/thread-130953-1-1.html 临床入组新药情报站-站长 Tue, 31 Mar 2026 07:55:59 +0000 肺癌“MRD检测”：是复发预警，还是治疗指南？一份权威共识来了 https://aww.yuaigongwu.com/thread-130952-1-1.html 临床入组新药情报站-站长 Tue, 31 Mar 2026 05:49:21 +0000